DGX * Stock Overview
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Quest Diagnostics Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2,458.05 |
| 52 Week High | US$2,775.98 |
| 52 Week Low | US$2,458.05 |
| Beta | 0.94 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -11.23% |
| 3 Year Change | -3.98% |
| 5 Year Change | n/a |
| Change since IPO | 20.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| DGX * | MX Healthcare | MX Market | |
|---|---|---|---|
| 7D | 0% | 3.4% | 1.3% |
| 1Y | -11.2% | 0.9% | 2.3% |
Return vs Industry: DGX * underperformed the MX Healthcare industry which returned -1.3% over the past year.
Return vs Market: DGX * underperformed the MX Market which returned 3.7% over the past year.
Price Volatility
| DGX * volatility | |
|---|---|
| DGX * Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in MX Market | 6.2% |
| 10% least volatile stocks in MX Market | 2.0% |
Stable Share Price: DGX * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine DGX *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 44,500 | Jim Davis | www.questdiagnostics.com |
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.
Quest Diagnostics Incorporated Fundamentals Summary
| DGX * fundamental statistics | |
|---|---|
| Market cap | Mex$266.42b |
| Earnings (TTM) | Mex$13.84b |
| Revenue (TTM) | Mex$168.50b |
19.2x
P/E Ratio1.6x
P/S RatioIs DGX * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DGX * income statement (TTM) | |
|---|---|
| Revenue | US$9.60b |
| Cost of Revenue | US$6.32b |
| Gross Profit | US$3.28b |
| Other Expenses | US$2.49b |
| Earnings | US$789.00m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.04 |
| Gross Margin | 34.16% |
| Net Profit Margin | 8.22% |
| Debt/Equity Ratio | 64.5% |
How did DGX * perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield39%
Payout RatioDoes DGX * pay a reliable dividends?
See DGX * dividend history and benchmarks| Quest Diagnostics dividend dates | |
|---|---|
| Ex Dividend Date | Jul 10 2023 |
| Dividend Pay Date | Jul 25 2023 |
| Days until Ex dividend | 303 days |
| Days until Dividend pay date | 288 days |
Does DGX * pay a reliable dividends?
See DGX * dividend history and benchmarks